NCT00003385View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

January 31, 2007

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

carboplatin

DRUG

paclitaxel

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (8)

44106

Ireland Cancer Center, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

96813

MBCCOP - Hawaii, Honolulu

52242-1009

Holden Comprehensive Cancer Center, Iowa City

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

77555-0587

University of Texas Medical Branch, Galveston

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

N-0310

Norwegian Radium Hospital, Oslo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00003385 - Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter